six medications could increase your risk of a heart attack are the medications you take daily silently increasing your risk of a heart attack in this crucial video we'll uncover six common drugs that could be jeopardizing your heart health without you even realizing it understanding these hidden dangers is vital for making informed decisions about your well-being if you're committed to safeguarding your health don't forget to subscribe to health 365 and and click the notification Bell by doing so you'll stay updated with our latest insights and tips to keep your heart in top condition one hormonal contraceptives
hormonal contraceptives Have Been instrumental in providing women with effective means of Family Planning and reproductive autonomy however their use has been associated with varying degrees of cardiovascular risk understanding these risks is crucial for informed decision-making regarding contraceptive options combined hormonal contraceptives chc's which include both estrogen and progestin are available in various forms such as pills patches and vaginal Rings Research indicates that chc's can Elevate the risk of arterial thrombotic events including myocardial infarction heart attack and Es schic stroke a comprehensive study involving over 2 million Danish women aged 15 to 49 observed that users of
estrogen progestin combination pills experienced a two-fold increase in the risk of these events specifically this translates to one additional stroke per 4,760 women and one additional heart attack per 10,000 women annually notably non-oral chc's demonstrated even higher risks for instance vaginal Rings were associated with a 3.8-fold increase in heart attack risk the underlying mechanism is believed to involve estrogen's influence on coagulation Pathways leading to a prothrombotic state estrogen can enhance the synthesis of clotting factors thereby increasing the likelihood of thrombus formation this effect is particularly concerning for women with additional risk factors such as smoking
hypertension or hyperlipidemia progestin only contraceptives available as pills injections implants or intrauterine devices iuds generally present a lower cardiovascular risk profile compared to chc's the same Danish study highlighted that progestin only methods were associated with a slightly elevated risk but significantly less so than their estrogen containing counterparts importantly the progest and only IUD did not show an increased risk of heart attack or stroke making it a safer option for women concerned about cardiovascular complications two non-steroidal anti-inflammatory drugs nids non-steroidal anti-inflammatory drugs nids are widely used to alleviate pain reduce inflammation and lower fevers common over-the-counter
IDs include ibuprofen and neoen while effective these medications have been associated with an increased risk of card cardiovascular events such as heart attacks and strokes nids exert their Effects by inhibiting cyc oxygenase Cox enzymes specifically Cox 1 and Cox 2 which play crucial roles in the production of prostaglandins lipid compounds that mediate inflammation and maintain various physiological functions inhibition of these enzymes can disrupt the balance between Vaso constriction and vasod dilation as well as platelet aggregation leading to an increased risk of thrombotic events this imbalance is particularly concerning in individuals with existing cardiovascular conditions numerous
Studies have highlighted the cardiovascular risks associated with nid use the US Food and Drug Administration FDA has emphasized that the risk of heart attack or stroke can occur as early as the first weeks of nid use and this risk may increase with longer use and higher doses importantly this risk applies to both over-the-counter and prescription nids a comprehensive review published in the European Cardiology review examined the cardiovascular implications of both traditional nids and Cox two selective Inhibitors coxibs the review underscored that net induced cardiovascular side effects have been overlooked for many years leading to increased
awareness of their potential risks not all n heads carry the same level of cardiovascular risk for instance diclofenac has been associated with a higher risk of major vascular events including heart attacks compared to other NSAIDs conversely Naproxin appears to have a more favorable cardiovascular risk profile among nids given the potential cardiovascular risks it is essential to use nids judiciously before initiating nid therapy evaluate the patient's cardiovascular history and risk factors prescribe the minimum effective dose for the shortest duration necessary to manage symptoms regularly monitor blood pressure and watch for signs of heart rated side effects
especially in long-term nid users for patients with high cardiovascular risk explore alternative pain management strategies that pose less risk three thool denian diabetes medications such as rosiglitazone rosiglitazone was designed to improve glycemic control in individuals with Type 2 Diabetes melitus by enhancing insulin sensitivity however concerns regarding its cardiovascular safety have significantly impacted its clinical use and Regulatory status rosiglitazone functions as a peroxisome proliferator activated receptor gamma PP gamma Agonist activation of pp gamma influences the transcription of genes involved in glucose and lipid metabolism leading to increased insulin sensitivity in peripheral tissues while this mechanism effectively
lowers blood glucose levels it also affects fluid balance and lipid profiles which may have implications for cardiovascular health the cardiovascular safety of rosiglitazone has been a subject of extensive research and debate a metaanalysis published in the New England Journal of Medicine in 2007 indicated a 43% increase in the risk of myocardial infarction among patients using rosiglitazone multiple Studies have consistently shown that rosiglitazone is associated with an increased risk of heart failure a comprehensive metaanalysis concluded that while there was no significant increase in myocardial infarction or cardiovascular mortality the risk of of heart failure was notably
higher observational Studies have yielded mixed results regarding the association between Ros aitone and stroke or all cause mortality some analyses suggest an elevated risk While others do not find a statistically significant increase the controversy surrounding Rosal glitazone underscores the importance of vigilant postmarketing surveillance and comprehensive evaluation of drug safety profiles clinicians must weigh the benefits of glycemic control against potential cardiovascular risks when considering thoolen for diabetes management alternative medications with more favorable safety profiles are often preferred especially in patients with existing cardiovascular disease or risk factors four certain anti-depressants tricylic anti-depressants tcas and selective serotonin
reuptake inhibitors ssris are widely used to manage depressive disorders while effective both classes have been associated with potential cardiovascular side effects which are important to consider when prescribing these medications tricyclic antidepressants tcas such as amitryptiline and nortryptiline function by inhibiting the re-uptake of neurotransmitters like norepinephrine and serotonin thereby enhancing mood however their phac ological profile affects various cardiac parameters tcas can cause a significant drop in blood pressure upon standing leading to dizziness and an increased risk of Falls this effect is primarily due to their antagonism of alpha adrenergic receptors these medications May prolong cardiac conduction
evident in increased PR QRS and QD intervals on an electrocardiogram ECG such changes can predispose patients to arrhythmias including ventricular tacac cardia and fibrillation tcas often cause tacac cardia due to their anti-cholinergic effects which can be problematic especially in patients with pre-existing heart conditions given these potential adverse effects caution is advised when prescribing tcas to individuals with cardiovascular disease alternative treatments may be preferable in such populations selective serotonin reuptake Inhibitors ssris including fluoxitine and caline selectively inhibit the re-uptake of Serotonin leading to mood Improvement they are generally considered to have a more favorable cardiovascular profile
compared to tcas some ssris notably Citalopram and a Citalopram have been associated with dose dependent QD interval prolongation which can increase the risk of of a rare but serious arhythmia known as torsades to points consequently the FDA recommends limiting the maximum daily dose of Citalopram to reduce this risk while less common than with tcas ssris can occasionally cause orthostatic hypotension and a slow heart rate these effects are generally mild but warrant monitoring especially in patients with existing cardiovascular concerns overall SS RIS are often preferred over tcas for patients with depression who have concurrent cardiovascular disease
due to their more favorable side effect profile however individual risk factors and potential drug interactions should always be considered five pseudo aedin pseudoephedrine a common decongestant in many over-the-counter cold and allergy medications is effective at relieving nasal congestion but it also o has potential cardiovascular effects especially for people with heart disease pseudoephedrine works by stimulating alpha-adrenergic receptors leading to the constriction of blood vessels in the nasal passages this vasoconstriction reduces swelling and allows for easier breathing however this effect is not limited to the nasal tissues pseudo aedin can cause Vaso constriction throughout the body potentially
impacting cardio iov vascular function pseudo aedin can elevate blood pressure and heart rate due to its systemic vasoconstrictive properties Studies have shown that in patients with controlled hypertension pseudo aedin may cause a modest increase in systolic blood pressure there have been reports linking pseudoephedrine use to acute coronary syndromes such as heart attacks the Drug's sympathic effects can increase myocardial oxygen demand potentially triggering cardiac events especially in susceptible individuals pseudo aedin May induce arrhythmias including tachicardia rapid heartbeat these effects are particularly concerning in individuals with underlying heart conditions or those taking other medications that affect heart
rhythm individuals with existing cardiovascular conditions such as hypertension or arrhythmias should consult their health care provider before using medications containing pseudo aedin alternative treatments with a more favorable cardiovascular profile may be recommended even in healthy individuals it's advisable to monitor blood pressure and heart rate when taking pseudo aedin especially if used in higher doses or for extended periods pseudo aedin can interact with other medications such as monoamine oxidase Inhibitors maois and beta blockers potentially exacerbating card cardiovascular effects informing Health Care Providers of all medications being taken is essential to avoid adverse interactions if you found
this video helpful please remember to hit the like button it really helps us bring you more valuable content drop a comment below and let us know your thoughts questions or what topic you'd like us to cover next we love hearing from you of course hit the Subscribe button and turn turn on notifications so you never miss out on our latest health tips and insights stay informed stay healthy and we'll see you in the next video
